Amy Lammayot

Statistics

Publications

Citations

219

H-Index

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Amy Lammayot is an author at The University of Texas MD Anderson Cancer Center specializing in her2-positive breast cancer, cell cycle inhibition, and cancer immunotherapy.

Publications per year

2003–2004

Publications

The Role of Cyclin-dependent Kinase Inhibitor p27Kip1 in Anti-HER2 Antibody-induced G1 Cell Cycle Arrest and Tumor Growth Inhibition

Xiao-Feng Le, François-Xavier Claret, Amy Lammayot et al. · Journal of Biological Chemistry · 2003 · 148 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling

Xiao‐Feng Le, Amy Lammayot, David Gold et al. · Journal of Biological Chemistry · 2004 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2